EQTN
gene geneOn this page
Also known as AFAFSPACA8equatorin
Summary
EQTN (equatorin, HGNC:1359) is a protein-coding gene on chromosome 9p21.2, encoding Equatorin (Q9NQ60). Acrosomal membrane-anchored protein involved in the process of fertilization and in acrosome biogenesis.
Predicted to be involved in acrosomal vesicle exocytosis; endocytosis; and fusion of sperm to egg plasma membrane involved in single fertilization. Predicted to act upstream of or within establishment of localization in cell. Predicted to be located in early endosome and nucleus. Predicted to be active in inner acrosomal membrane; outer acrosomal membrane; and plasma membrane.
Source: NCBI Gene 54586 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 60 total
- MANE Select transcript:
NM_020641
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1359 |
| Approved symbol | EQTN |
| Name | equatorin |
| Location | 9p21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | AFAF, SPACA8, equatorin |
| Ensembl gene | ENSG00000120160 |
| Ensembl biotype | protein_coding |
| OMIM | 617653 |
| Entrez | 54586 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000380031, ENST00000380032, ENST00000484994, ENST00000537675
RefSeq mRNA: 2 — MANE Select: NM_020641
NM_001161585, NM_020641
CCDS: CCDS35001, CCDS55300
Canonical transcript exons
ENST00000380032 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000813552 | 27286209 | 27286362 |
| ENSE00000813553 | 27289672 | 27289731 |
| ENSE00000813554 | 27291019 | 27291063 |
| ENSE00000813555 | 27292401 | 27292487 |
| ENSE00000813556 | 27294316 | 27294402 |
| ENSE00000813557 | 27296613 | 27296738 |
| ENSE00001483487 | 27284654 | 27284972 |
| ENSE00001483492 | 27296980 | 27297150 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 95.36.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0752 / max 59.9943, expressed in 4 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 100328 | 0.0302 | 4 |
| 100329 | 0.0269 | 3 |
| 100330 | 0.0181 | 3 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 95.36 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.87 | gold quality |
| left testis | UBERON:0004533 | 90.65 | gold quality |
| right testis | UBERON:0004534 | 90.40 | gold quality |
| testis | UBERON:0000473 | 88.00 | gold quality |
| adult organism | UBERON:0007023 | 71.55 | gold quality |
| corpus callosum | UBERON:0002336 | 61.90 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 57.44 | gold quality |
| ventricular zone | UBERON:0003053 | 57.09 | gold quality |
| spinal cord | UBERON:0002240 | 55.86 | gold quality |
| mucosa of stomach | UBERON:0001199 | 55.63 | gold quality |
| left ovary | UBERON:0002119 | 55.27 | gold quality |
| right lung | UBERON:0002167 | 52.83 | gold quality |
| rectum | UBERON:0001052 | 52.67 | gold quality |
| right ovary | UBERON:0002118 | 52.56 | gold quality |
| ovary | UBERON:0000992 | 52.13 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 50.68 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 49.70 | gold quality |
| tibial artery | UBERON:0007610 | 49.55 | gold quality |
| popliteal artery | UBERON:0002250 | 49.40 | gold quality |
| transverse colon | UBERON:0001157 | 49.31 | gold quality |
| left uterine tube | UBERON:0001303 | 49.06 | gold quality |
| tibial nerve | UBERON:0001323 | 49.02 | gold quality |
| body of stomach | UBERON:0001161 | 48.97 | gold quality |
| small intestine | UBERON:0002108 | 48.65 | gold quality |
| left coronary artery | UBERON:0001626 | 48.46 | gold quality |
| substantia nigra | UBERON:0002038 | 48.20 | gold quality |
| body of pancreas | UBERON:0001150 | 48.00 | gold quality |
| aorta | UBERON:0000947 | 47.84 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 47.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.58 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- A genome-wide association study finds that the chromosome 9p21 locus is a major cause of familial amyotrophic lateral sclerosis in the Finnish population. (PMID:20801718)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Eqtn | ENSMUSG00000028575 |
| rattus_norvegicus | Eqtn | ENSRNOG00000026323 |
Protein
Protein identifiers
Equatorin — Q9NQ60 (reviewed: Q9NQ60)
Alternative names: Acrosome formation-associated factor
All UniProt accessions (1): Q9NQ60
UniProt curated annotations — full annotation on UniProt →
Function. Acrosomal membrane-anchored protein involved in the process of fertilization and in acrosome biogenesis.
Subunit / interactions. Interacts with SNAP25.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome membrane. Acrosome inner membrane. Acrosome outer membrane.
Tissue specificity. Isoform 1 is highly expressed in testis. Isoform 2 is expressed at low levels in skin and blood.
Post-translational modifications. Highly N- and O-glycosylated; contains sialic acid.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NQ60-1 | 1 | yes |
| Q9NQ60-2 | 2 | |
| Q9NQ60-3 | 3 |
RefSeq proteins (2): NP_001155057, NP_065692* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029282 | Eqtn/Afaf | Family |
Pfam: PF15339
UniProt features (15 total): splice variant 3, sequence variant 3, topological domain 2, glycosylation site 2, signal peptide 1, chain 1, sequence conflict 1, transmembrane region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NQ60-F1 | 59.20 | 0.10 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 76, 143
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
GOBP_SINGLE_FERTILIZATION, GOCC_SECRETORY_GRANULE, GOBP_MEMBRANE_FUSION, GOBP_PLASMA_MEMBRANE_ORGANIZATION, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_EXOCYTOSIS, GOBP_SECRETION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_ACROSOME_REACTION, GOBP_PLASMA_MEMBRANE_FUSION, GOBP_MEMBRANE_ORGANIZATION, GOBP_FERTILIZATION, GOBP_IMPORT_INTO_CELL
GO Biological Process (3): endocytosis (GO:0006897), fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342), acrosomal vesicle exocytosis (GO:0060478)
GO Molecular Function (0):
GO Cellular Component (6): inner acrosomal membrane (GO:0002079), outer acrosomal membrane (GO:0002081), plasma membrane (GO:0005886), acrosomal membrane (GO:0002080), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| acrosomal membrane | 2 |
| cytoplasmic vesicle membrane | 2 |
| vesicle budding from membrane | 1 |
| membrane invagination | 1 |
| vesicle-mediated transport | 1 |
| import into cell | 1 |
| single fertilization | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| acrosome reaction | 1 |
| calcium-ion regulated exocytosis | 1 |
| membrane | 1 |
| cell periphery | 1 |
| acrosomal vesicle | 1 |
| secretory granule membrane | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
1270 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EQTN | MOB3B | Q86TA1 | 542 |
| EQTN | FAM170B | A6NMN3 | 486 |
| EQTN | TEX101 | Q9BY14 | 461 |
| EQTN | IZUMO1 | Q8IYV9 | 442 |
| EQTN | SPAM1 | P38567 | 430 |
| EQTN | CD9 | P21926 | 426 |
| EQTN | PATE4 | P0C8F1 | 399 |
| EQTN | GLT1D1 | Q96MS3 | 396 |
| EQTN | SPMIP6 | Q8NCR6 | 395 |
| EQTN | DEFB126 | Q9BYW3 | 386 |
| EQTN | CLGN | O14967 | 385 |
| EQTN | ADAM30 | Q9UKF2 | 382 |
| EQTN | ADAM2 | P78326 | 378 |
| EQTN | NT5C1B | Q96P26 | 370 |
| EQTN | CABYR | O75952 | 368 |
| EQTN | MAN2A2 | P49641 | 368 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A7H0DND5, A8DYY6, F5HGU6, F5HI32, H2KZ49, P06817, P16192, P16196, P16200, P16204, P16206, P16208, P27908, P33304, P33852, P34718, P36358, P46946, P55082, P67908, P67909, P68618, P68619, P69338, P69339, Q00682, Q03345, Q04922, Q05569, Q05611, Q06693, Q08729, Q09560, Q10034, Q20646, Q23647, Q2M2T8, Q5R9E4, Q5UQ18, Q5UQI5
Diamond homologs: Q2LCV6, Q9D9V2, Q9NQ60
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
819 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:27284973:C:CC | acceptor_gain | 1.0000 |
| 9:27286204:CTTA:C | donor_loss | 1.0000 |
| 9:27286205:TTACC:T | donor_loss | 1.0000 |
| 9:27286206:TACC:T | donor_loss | 1.0000 |
| 9:27286207:A:AC | donor_gain | 1.0000 |
| 9:27286207:A:C | donor_loss | 1.0000 |
| 9:27286208:C:CA | donor_gain | 1.0000 |
| 9:27286208:CCT:C | donor_gain | 1.0000 |
| 9:27286358:AGACT:A | acceptor_gain | 1.0000 |
| 9:27286359:GACT:G | acceptor_gain | 1.0000 |
| 9:27286361:CT:C | acceptor_gain | 1.0000 |
| 9:27286361:CTCT:C | acceptor_loss | 1.0000 |
| 9:27286363:C:CC | acceptor_gain | 1.0000 |
| 9:27292399:A:AC | donor_gain | 1.0000 |
| 9:27292400:C:CC | donor_gain | 1.0000 |
| 9:27294400:CAT:C | acceptor_gain | 1.0000 |
| 9:27296612:CATTG:C | donor_gain | 1.0000 |
| 9:27284968:TATAA:T | acceptor_gain | 0.9900 |
| 9:27284970:TAA:T | acceptor_gain | 0.9900 |
| 9:27286207:AC:A | donor_gain | 0.9900 |
| 9:27286208:CC:C | donor_gain | 0.9900 |
| 9:27289729:TAG:T | acceptor_gain | 0.9900 |
| 9:27289731:GC:G | acceptor_loss | 0.9900 |
| 9:27289732:C:CC | acceptor_gain | 0.9900 |
| 9:27289733:T:TC | acceptor_loss | 0.9900 |
| 9:27289734:G:C | acceptor_loss | 0.9900 |
| 9:27289741:CAAA:C | acceptor_loss | 0.9900 |
| 9:27289742:A:T | acceptor_loss | 0.9900 |
| 9:27292341:A:C | donor_gain | 0.9900 |
| 9:27294398:CACAT:C | acceptor_gain | 0.9900 |
AlphaMissense
1953 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:27284912:A:C | F232L | 0.992 |
| 9:27284912:A:T | F232L | 0.992 |
| 9:27284914:A:G | F232L | 0.992 |
| 9:27291035:C:A | W135C | 0.987 |
| 9:27291035:C:G | W135C | 0.987 |
| 9:27284879:A:C | F243L | 0.986 |
| 9:27284879:A:T | F243L | 0.986 |
| 9:27284881:A:G | F243L | 0.986 |
| 9:27291037:A:G | W135R | 0.984 |
| 9:27291037:A:T | W135R | 0.984 |
| 9:27286243:A:G | C201R | 0.980 |
| 9:27294396:A:G | F70S | 0.974 |
| 9:27291038:A:C | F134L | 0.971 |
| 9:27291038:A:T | F134L | 0.971 |
| 9:27291040:A:G | F134L | 0.971 |
| 9:27294349:C:G | A86P | 0.970 |
| 9:27286238:A:C | S202R | 0.968 |
| 9:27286238:A:T | S202R | 0.968 |
| 9:27286240:T:G | S202R | 0.968 |
| 9:27284913:A:C | F232C | 0.967 |
| 9:27291027:A:G | L138S | 0.965 |
| 9:27286248:G:T | A199E | 0.961 |
| 9:27294360:A:G | I82T | 0.961 |
| 9:27291039:A:C | F134C | 0.959 |
| 9:27291039:A:G | F134S | 0.959 |
| 9:27294354:A:T | V84E | 0.958 |
| 9:27291019:C:G | A141P | 0.957 |
| 9:27286291:C:G | G185R | 0.954 |
| 9:27286291:C:T | G185R | 0.954 |
| 9:27294360:A:T | I82K | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000009159 (9:27297884 T>C), RS1000151836 (9:27290900 G>A,C), RS1000236109 (9:27287160 C>G), RS1000246030 (9:27287390 A>T), RS1000573482 (9:27288561 C>T), RS1000579643 (9:27287784 A>G), RS1000706511 (9:27297936 G>A,C,T), RS1001195276 (9:27298214 A>G), RS1001219407 (9:27296804 T>C), RS1001303804 (9:27292815 T>C), RS1001450592 (9:27287525 C>T), RS1001530510 (9:27286286 G>A,T), RS1001565255 (9:27291852 C>T), RS1001582849 (9:27286526 A>G), RS1001859208 (9:27287789 T>C)
Disease associations
OMIM: gene MIM:617653 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_81 | Obesity-related traits | 6.000000e-06 |
| GCST003831_45 | Asthma | 7.000000e-10 |
| GCST003831_47 | Asthma | 2.000000e-08 |
| GCST003833_23 | Adult asthma | 3.000000e-07 |
| GCST003833_24 | Adult asthma | 2.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases methylation, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Particulate Matter | decreases methylation, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.